ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Terns Pharmaceuticals Inc

Terns Pharmaceuticals Inc (TERN)

5.86
-0.19
(-3.14%)
Closed December 22 4:00PM
5.80
-0.06
(-1.02%)
After Hours: 7:58PM

Income Statement

Balance Sheet

Cash Flow

Quarter End Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 00000000
Operating Income -16.83M-24.16M-21.16M-33.18M-24.06M-25.45M-25.54M-24.94M
Pre Tax Income -15.5M-21.47M-17.82M-29.71M-20.97M-22.28M-22.68M-21.88M
Net Income -15.82M-21.53M-17.9M-29.77M-21.02M-22.37M-22.74M-21.95M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -16.83M-24.16M-21.22M-33.19M-24.3M-25.46M-25.55M-24.97M
EBITDA -16.74M-24.08M-21.09M-33.11M-23.99M-25.36M-25.45M-24.86M
Year End December 30 2023 201820192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 0001M00
Operating Income -18.46M-70.2M-37.03M-49.86M-62.03M-102.56M
Pre Tax Income -18.09M-68.84M-39.76M-49.65M-59.99M-89.97M
Net Income -17.71M-68.61M-29.35M-50.16M-60.35M-90.21M
Preferred Dividends 000000
Basic Earnings Per Share (EPS) -12.073-22.704-86.84-1.985-1.123-1.46
EBIT -18.42M-70.04M-39.81M-49.82M-62.1M-102.87M
EBITDA -18.39M-70M-36.63M-49.35M-61.55M-102.27M

Your Recent History

Delayed Upgrade Clock